Shiseido

Last updated January 31, 2026

Innovation Areas

1,496

Inventors

Collaborations

Apj and m2 macrophage modulators: ShiseidoRecent Research Landscape

Dermal pigmentation and photoaging are driven by chronic inflammatory responses that degrade the extracellular matrix. These innovations modulate the immune microenvironment by specifically activating M2-type macrophages to suppress melanin deposition and repair tissue.

What technical problems is Shiseido addressing in Apj and m2 macrophage modulators?

Dermal pigment deposition

(5)evidences

Uncontrolled melanin accumulation and signal-driven hyperpigmentation within the dermis. Resolving this prevents aesthetic degradation and pathological skin discoloration.

Insufficient stem cell activation

(5)evidences

Loss of skin structural integrity and regenerative capacity due to stem cell exhaustion and immune senescence. Addressing this prevents dermal cavitation and visible skin looseness.